Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.043 0.6
mRNA birinapant CTRPv2 pan-cancer AAC 0.023 0.6
mRNA WP1130 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA paclitaxel UHNBreast pan-cancer AAC -0.19 0.6
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.031 0.6
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA MI-2 CTRPv2 pan-cancer AAC -0.031 0.6
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.022 0.6
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.022 0.6
Download CSV